Premium
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine
Author(s) -
Relling MV,
Krauss RM,
Roden DM,
Klein TE,
Fowler DM,
Terada N,
Lin L,
RielMehan M,
Do TP,
Kubo M,
Yee SW,
Johnson GT,
Giacomini KM
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.755
Subject(s) - pharmacogenomics , translational research , drug response , precision medicine , computational biology , data science , bioinformatics , medicine , computer science , biology , microbiology and biotechnology , drug , pharmacology , genetics
The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community‐driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.